Posted by Hanz Christensen on Feb 5th, 2026
Boston Scientific (NYSE:BSX) outlined strong 2025 results and issued guidance for continued growth in 2026, highlighting broad-based performance across multiple business units, expanding operating margins, and an active pipeline of...
More of this article »